Biota Pharma (BOTA) Reports Q4 Loss of $0.55/Share

Biota Pharma (NASDAQ: BOTA) reported Q4 EPS of ($0.55), versus ($0.29) reported last year. Revenue for the quarter came in at $4.1 million, versus $8.5 million reported last year.

For earnings history and earnings-related data on Biota Pharma (BOTA) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
• ScanSource (SCSC) Tops Q4 EPS by 32c